rs780596734
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000232.5(SGCB):c.622-2A>G variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,609,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000232.5 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.622-2A>G | splice_acceptor_variant | ENST00000381431.10 | NP_000223.1 | |||
SGCB | XM_047416074.1 | c.412-2A>G | splice_acceptor_variant | XP_047272030.1 | ||||
SGCB | XM_047416075.1 | c.325-2A>G | splice_acceptor_variant | XP_047272031.1 | ||||
SGCB | XM_047416076.1 | c.325-2A>G | splice_acceptor_variant | XP_047272032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.622-2A>G | splice_acceptor_variant | 1 | NM_000232.5 | ENSP00000370839 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250836Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135650
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1457652Hom.: 0 Cov.: 28 AF XY: 0.00000551 AC XY: 4AN XY: 725374
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 08, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 05, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Nov 24, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change affects an acceptor splice site in intron 4 of the SGCB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). This variant is present in population databases (rs780596734, gnomAD 0.003%). Disruption of this splice site has been observed in individuals with limb-girdle muscular dystrophy (PMID: 12566530). ClinVar contains an entry for this variant (Variation ID: 370115). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at